| Laura R Shuler-mckinney, MD | |
|
8629 Bluejacket St, Suite 100, Lenexa, KS 66214-1604 | |
| (913) 677-3553 | |
| (913) 677-3282 |
| Full Name | Laura R Shuler-mckinney |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 8629 Bluejacket St, Lenexa, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487699302 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 066 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laura R Shuler-mckinney, MD 8629 Bluejacket St, Suite 100, Lenexa, KS 66214-1604 Ph: (913) 677-3553 | Laura R Shuler-mckinney, MD 8629 Bluejacket St, Suite 100, Lenexa, KS 66214-1604 Ph: (913) 677-3553 |
News Archive
In response to two suspected SARS cases reported in China, Taiwan Department of Health has announced today that starting from April 24, the SARS responsive level will be escalated to level A or Code Red, the highest state of alert.
New research with transgenic mice reveals that a therapy directed at the muscle significantly improves disease symptoms of a genetic disorder characterized by destruction of the neurons that control movement. The study, published by Cell Press in the August 13th issue of the journal Neuron, highlights a promising new treatment for this currently incurable and nontreatable neurodegenerative disorder.
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that it has received notification from the US Food and Drug Administration (FDA) that the Agency is currently drafting a response to the Company relating to the Investigational New Drug (IND) Application it filed in November seeking clearance to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD).
To promote the establishment of universal standards for prescription medication labels-and to address the widespread problem of patient misinterpretation of medication instructions-an advisory panel formed by the U.S. Pharmacopeial Convention (USP) recently issued a set of recommendations to bring consistency to labeling on dispensed prescription packaging.
› Verified 3 days ago
Marc A Schlosberg, PH D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 8629 Bluejacket St, Suite 100, Lenexa, KS 66214 Phone: 913-677-3553 Fax: 913-677-3282 | |
Jimmie Gene Lemons, ED.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 15700 College Blvd, Suite 201, Lenexa, KS 66219 Phone: 913-383-8977 Fax: 913-383-3116 | |
Douglas Hippe, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 12805 W 100th Ter, Lenexa, KS 66215 Phone: 913-271-7899 Fax: 913-894-1329 | |
Donna Jane Dassel-stuke, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8325 Lenexa Dr Ste 150, Lenexa, KS 66214 Phone: 913-652-9229 | |
Ms. Alexandria L Kaplan, LMLP-T Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St Ste 100, Lenexa, KS 66214 Phone: 913-677-3553 | |
Ms. Cassandra Ann Thompson, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St, Suite 100, Lenexa, KS 66214 Phone: 913-677-3553 Fax: 913-677-3282 | |
Bambi Burgard, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St, Suite 102, Lenexa, KS 66214 Phone: 913-677-0500 Fax: 913-677-5243 |